In the phase I PASTOR study (NCT02599714), postmenopausal patients with ER+/HER2− locally advanced ABC or MBC previously treated by hormonal therapy were divided into two treatment arms of a randomized trial. Here, ESR1 is linked to aneurysmal bone cyst.